These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 16684222

  • 1. Immunoadsorption plasmapheresis using a phenylalanine column as an effective treatment for lupus nephritis.
    Sugimoto K, Yamaji K, Yang KS, Kanai Y, Tsuda H, Hashimoto H.
    Ther Apher Dial; 2006 Apr; 10(2):187-92. PubMed ID: 16684222
    [Abstract] [Full Text] [Related]

  • 2. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
    Funauchi M, Ikoma S, Imada A, Kanamaru A.
    J Clin Lab Immunol; 1997 Apr; 49(2):47-57. PubMed ID: 9819673
    [Abstract] [Full Text] [Related]

  • 3. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Crossroads of the effects of cyclophosphamide pulse therapy for lupus nephritis--experience of 11 cases.
    Funauchi M, Ikoma S, Sugiyama M, Yu H, Ohno M, Kinoshita K, Hamada K, Kanamaru A.
    J Clin Lab Immunol; 1998 Sep 02; 50(2):45-54. PubMed ID: 10470622
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the outcome of lupus nephritis according to long-term treatment employing different modes of immunotherapy.
    Hashimoto H, Sugawara M, Tsuda H, Kabasawa K, Hirose S.
    Nihon Jinzo Gakkai Shi; 1992 Sep 02; 34(9):1003-9. PubMed ID: 1479728
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Double blind trial of pulse methylprednisolone versus conventional oral prednisolone in lupus nephritis].
    Honma M, Ichikawa Y, Akizuki M, Kashiwazaki S, Kondo H, Hashimoto H, Sugawara M, Hanaoka K.
    Ryumachi; 1994 Jun 02; 34(3):616-27. PubMed ID: 8052927
    [Abstract] [Full Text] [Related]

  • 14. The course of anticardiolipin antibody levels under immunoadsorption therapy.
    Hauser AC, Hauser L, Pabinger-Fasching I, Quehenberger P, Derfler K, Hörl WH.
    Am J Kidney Dis; 2005 Sep 02; 46(3):446-54. PubMed ID: 16129206
    [Abstract] [Full Text] [Related]

  • 15. Therapy of lupus nephritis. A two-year prospective study.
    Doria A, Piccoli A, Vesco P, Vaccaro E, Marson P, De Silvestro G, Ossi E, Gambari P.
    Ann Med Interne (Paris); 1994 Sep 02; 145(5):307-11. PubMed ID: 7985937
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictive factors of clinical outcome in patients with diffuse proliferative lupus nephritis treated early by intravenous methylprednisolone pulse therapy.
    Kanno A, Hotta O, Yusa N, Taguma Y.
    Ren Fail; 2007 Sep 02; 29(1):41-7. PubMed ID: 17365909
    [Abstract] [Full Text] [Related]

  • 19. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
    Arthritis Rheum; 2007 Mar 02; 56(3):924-37. PubMed ID: 17328070
    [Abstract] [Full Text] [Related]

  • 20. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
    Biesenbach P, Schmaldienst S, Smolen JS, Hörl WH, Derfler K, Stummvoll GH.
    Atheroscler Suppl; 2009 Dec 29; 10(5):114-21. PubMed ID: 20129388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.